July 17, 2026 – Safety and Efficacy in Discovery of drug-like inhibitors

The patient was also prescribed erlotinib (150 mg, once per day)

The patient was also prescribed erlotinib (150 mg, once per day). identical genetic profile. The MUC16 bone lesion was identified to be a metastasis from the lung cancer. The patient was prescribed an epithelial growth factor receptor inhibitor, which resulted in a partial response in the lung mass and alleviation of the patient’s bone pain. […]

by igesip

IHC analysis revealed that although differences in basal c-MET protein levels could be detected between individual tumors, no increased c-MET protein levels were observed between the central and budding cells in individual tumors (Supplementary Figure S6)

IHC analysis revealed that although differences in basal c-MET protein levels could be detected between individual tumors, no increased c-MET protein levels were observed between the central and budding cells in individual tumors (Supplementary Figure S6). == DISCUSSION == The establishment of metastasis following the development of a primary tumor, requires a number of well-defined […]

by igesip

Day: July 17, 2026

﻿The patient was also prescribed erlotinib (150 mg, once per day)

﻿IHC analysis revealed that although differences in basal c-MET protein levels could be detected between individual tumors, no increased c-MET protein levels were observed between the central and budding cells in individual tumors (Supplementary Figure S6)

The patient was also prescribed erlotinib (150 mg, once per day)

IHC analysis revealed that although differences in basal c-MET protein levels could be detected between individual tumors, no increased c-MET protein levels were observed between the central and budding cells in individual tumors (Supplementary Figure S6)